Celeste, M. G.; De Marco, F.; Fresco, C.; Musumeci, G.; Ravasio, R. Budget Impact Analysis of Dabigatran Compared With Rivaroxaban in the Prevention of the Thromboembolic Risk in Patients With Non-Valvular Atrial Fibrillation. FE 2017, 18.